In some cases, HDL, the “good cholesterol,” may not function properly and may actually accelerate atherosclerosis.
Vanderbilt investigators have demonstrated in two studies that metformin-based treatments delay the onset and progression of chronic kidney disease (CKD) compared with other treatments for diabetes.
Low oxygen – and the activation of factors that respond to this situation – may be protective in chronic kidney disease.
Accessibility Tools